Sutent (sunitinib) 50 mg capsules, 14 capsules — original (Pfizer, Italy) Sutent (sunitinib) Targeted cancer therapy. Delivery from Europe within 4-5 days, storage conditions are met, payment upon receipt. Order by calling +380996042415.

Indications:

• Metastatic renal cell carcinoma (MRCC).
• Sutent is indicated for the treatment of advanced and/or metastatic renal cell carcinoma.
• Gastrointestinal stromal tumors (GST).
• Gastrointestinal stromal tumors (GST) after failure of imatinib mesylate due to resistance or intolerance.
• Pancreatic neuroendocrine tumors (NSAIDs).
• Sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors with disease progression in adults. Experience with Sutent as a first-line treatment is limited. misha95
• 8kar7neizb